Laurence Hicks serves as Executive at Arch Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Laurence Hicks has executed 2 insider transactions totaling $2.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 31, 2023 involved purchasing 10,292 shares valued at $2.9K.
Laurence Hicks currently holds 10,292 shares of Arch Therapeutics, Inc. (ARTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laurence Hicks has been a net buyer of ARTH stock. They have purchased $2.9K and sold $0 worth of shares.
Laurence Hicks's most recent insider trade was on Aug 31, 2023, when they purchased 10,292 shares at $0.28 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |